CT guided pararectal seed implant for localized prostate cancer: a preliminary report

N E Adeeb; J C Christodoulides; J F Derosas; D B Doyle; R G Fugitt; C R Gona; J M Greco; S E Lillie; I A Mohamed; J M Roehmholdt; J J Shin; P A Swiantek; J S Sosnowski

CT guided pararectal seed implant for localized prostate cancer: a preliminary report

J Med. 2002;33(1-4):63-71.

Authors

N E Adeeb¹, J C Christodoulides, J F Derosas, D B Doyle, R G Fugitt, C R Gona, J M Greco, S E Lillie, I A Mohamed, J M Roehmholdt, J J Shin, P A Swiantek, J S Sosnowski

Affiliation

¹ CCS Oncology Center, Kenmore, New York 14217, USA.

PMID: 12939105

Abstract

One hundred and fifty-two patients were treated with CT guided pararectal prostate seed implant (CPSI) alone or in combination with external-beam 3D conformal radiation therapy (EB3DRT) and Androgen Blockage Hormone Therapy (HT). A decrease and normalization in PSA values was seen following treatment in all groups. However, a better therapeutic response was observed in the individuals that received CPSI and EB3DRT with hormone therapy.

MeSH terms

Adenocarcinoma / diagnostic imaging
Adenocarcinoma / drug therapy
Adenocarcinoma / radiotherapy*
Aged
Aged, 80 and over
Brachytherapy / methods*
Humans
Iodine Radioisotopes / therapeutic use
Male
Middle Aged
Prostatic Neoplasms / diagnostic imaging
Prostatic Neoplasms / drug therapy
Prostatic Neoplasms / radiotherapy*
Radiotherapy, Conformal
Tomography, X-Ray Computed

Substances

Iodine Radioisotopes